The medicines regulator is suggesting the minimum age limit for trial should be raised to 14.

Regulatory clearance enables start of clinical testing and marks transition to clinical-stage companyOn track for initial clinical data to emerge from mid-2026Oslo, Norway, 20 February 2026 - Zelluna ...

Swiss pharma giant Novartis today announced that Pluvicto (plutetium-177 vipivotide tetraxetan) has received MHRA approval ...

The CEO of the Medicines and Healthcare products Regulatory Agency is set to leave the agency in 10 months. Ian Hudson’s decision means the agency faces the prospect of changing leaders while dealing ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Ziihera (zanidatamab) for use in adults to treat biliary tract cancer (cancer of the structures that store and ...

“ PATHWAYS TRIAL is a Clinical Trial of an Investigational Medicine Product (CTIMP) and was approved via combined review from the HRA and a Research Ethics Committee entirely independent of the ...

INmune Bio (INMB) has formally submitted its pre-submission package for CORDStrom with the United Kingdom’s Medicines and ...

Launched today by the Medicines and Healthcare products Regulatory Agency (the MHRA), the seventh annual #MedSafetyWeek is running until 13 November to encourage widespread public engagement and ...

Clinical trial into puberty blockers paused after ‘new concerns’ from medicines regulator - The MHRA will now discuss the ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved guselkumab (Tremfya) for the treatment of Crohn’s disease and ulcerative colitis (UC). Already used for plaque psoriasis and ...

The MHRA has launched a consultation on proposals for indefinite recognition of CE-marked medical devices in Great Britain.